Sepsis is a condition wherein the body’s response to infection triggers an inflammation reaction throughout the body. The immune system releases inflammatory chemicals into the bloodstream to clear out pathogens from the body, but instead these chemicals cause a cascade of reactions that result in organ damage and may be fatal. A few of the symptoms of sepsis include low blood pressure, mental confusion, fever, an increased heart rate, and difficulty breathing. Sepsis may be caused by infectious agents such as bacteria, viruses, and fungi. Several factors that increase the risk of sepsis include old age, diabetes, liver disease, the use of antibiotics, and the use of invasive medical devices such as catheters.
Market Dynamics
Market players are conducting clinical trials for developing more efficient diagnostic systems for sepsis, which could contribute to the growth of the market over the forecast period. For instance, in February 2020, Inflammatix, Inc., a California, U.S. based diagnostics company, initiated a clinical trial study for their product HostDx Sepsis with 1500 participants, which is expected to be completed by November 2021. This clinical study investigates the performance of the HostDx Sepsis diagnostic test in the diagnosis and prognosis of patients with suspected sepsis.
Market players are involved in expanding their presence globally by entering into collaboration with other companies in order to enhance distribution, which is expected to drive the growth of the global sepsis diagnostics market. For instance, in May 2020, BARDA (Biomedical Advanced Research and Development Authority) and Beckman Coulter Inc., a California, U.S. based biomedical testing solutions provider, entered into a strategic collaboration for the development of a diagnostic algorithm for early detection of sepsis in COVID-19 patients.
Key features of the study:
- This report provides an in-depth analysis of the global sepsis diagnostics market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global sepsis diagnostics market based on the following parameters– company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include BioMérieux SA, Thermo Fisher Scientific, Abbott Laboratories, Roche Diagnostics AG, Luminex Corporation, CytoSorbents Corporation, Becton Dickinson Company, Danaher Corporation, Axis-Shield Diagnostics, T2 Biosystems, EKF Diagnostics, Immunexpress Inc., Response Biomedical Corporation, and Bruker Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global sepsis diagnostics marketreport caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sepsis diagnostics market.
Detailed Segmentation:
- Global Sepsis Diagnostics Market, By Product Type:
- Blood Culture Media
- Assays & Reagents
- Instruments
- Software
- Global Sepsis Diagnostic Market, By Method:
- Automated Diagnostics
- Conventional Diagnostics
- Global Sepsis Diagnostics Market, By Pathogen:
- Bacterial Sepsis
- Gram-Negative Bacterial Sepsis
- Gram-Positive Bacterial Sepsis
- Fungal Sepsis
- Others
- Global Sepsis Diagnostic Market, By Technology:
- Microbiology
- Molecular Diagnostics
- Immunoassays
- Flow Cytometry
- Global Sepsis Diagnostic Market, By End User:
- Hospitals
- Pathology & Reference Laboratories
- Research Laboratories & Academic Institutes
- Global Sepsis Diagnostic Market, By Region:
- North America
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- Company Profiles
- BioMérieux SA
- Thermo Fisher Scientific
- Abbott Laboratories
- Roche Diagnostics AG
- Luminex Corporation
- CytoSorbents Corporation
- Becton Dickinson Company
- Danaher Corporation
- Axis-Shield Diagnostics
- T2 Biosystems
- EKF Diagnostics
- Immunexpress Inc.
- Response Biomedical Corporation
- Bruker Corporation
